Cardiovascular Diseases in the Patients With Psoriatic Arthritis

Anum Akhlaq1, Huma Fatima Ali2, Abu Baker Sheikh3

  • 1Department of Internal Medicine, University of Mississippi Medical Center, MS, USA.

Insights

Cardiovascular disease hospitalizations, including heart failure, heart attack, and stroke, showed an increasing trend in psoriatic arthritis patients. While costs decreased for heart failure, overall mortality and length of stay remained unchanged.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Psoriatic arthritis (PsA) is associated with an increased risk of cardiovascular diseases (CVD).
  • Limited data exists on the national burden and trends of CVD hospitalizations in PsA patients.

Purpose of the Study:

  • To analyze hospitalization trends for heart failure (HF), acute myocardial infarction (AMI), and stroke in adults with PsA.
  • To evaluate in-hospital mortality, length of stay (LOS), and inflation-adjusted costs associated with these hospitalizations.

Main Methods:

  • Analysis of the National Inpatient Sample (NIS) database from January 2005 to December 2018.
  • Examination of age-adjusted hospitalization percentages for HF, AMI, and stroke among PsA patients.
  • Assessment of trends in in-hospital mortality, LOS, and inflation-adjusted costs.

Main Results:

  • Age-adjusted HF hospitalizations decreased then increased, with a significant trend over time (P-trend 0.044).
  • AMI hospitalizations showed a non-significant decreasing trend followed by a non-significant increase (P-trend 0.056).
  • Age-adjusted stroke hospitalizations demonstrated a significant increasing trend (P-trend 0.036).
  • No significant changes in inpatient mortality or LOS were observed; inflation-adjusted costs decreased for HF hospitalizations.

Conclusions:

  • There is an increasing trend of cardiovascular hospitalizations in patients with psoriatic arthritis.
  • Findings highlight the need for increased awareness and further research into CVD management in PsA.
  • These results can inform clinical practice for managing cardiovascular risks in PsA patients.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
51
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
73
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
101
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
60
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
48
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
97